Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Exec appointment
confidence 85%
filed 2026-07-23
Item 5.02
Nicolas Calcoen, a senior Amundi executive (Deputy CEO, Head of Strategy, Finance and Control), was appointed as a Class III director of Victory Capital Holdings effective July 23, 2026, replacing Dominique Carrel-Billiard who resigned the same date due to his departure from Amundi. The appointment was recommended by the Nominating Committee and is presented as a strategic addition to the Board.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-23
Item 5.02
Dr. Shantanu K. Gaur resigned as Chief Executive Officer and board member effective immediately on July 17, 2026. This is a departure of the company's principal executive officer, which is material to investors. While the filing notes the COO will oversee day-to-day operations, the central disclosed action is the CEO's resignation, not an appointment or compensation arrangement.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-23
Item 2.02
Ovintiv disclosed second quarter 2026 financial and operating results, reporting net earnings of $456 million ($1.62 per share diluted), along with cash flow metrics, production volumes, capital expenditures, and revised full-year 2026 guidance.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-07-23
Item 8.01
Ovintiv's Board declared a quarterly dividend of $0.30 per share payable September 29, 2026 to shareholders of record as of September 15, 2026, consistent with the company's shareholder return framework.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-23
Item 8.01
The disclosure centers on the Board-approved appointment of William Clement as Chief Commercial Officer effective August 1, 2026, a senior executive role reporting to the CEO with responsibility for commercial strategy and the independent agent network. While the filing also mentions transitions for Jim Applegate and Matthew Dannegger, Clement's appointment is the primary announced action and the most material event—a new C-suite officer joining the Executive Leadership Team at a major transportation company. The appointment would affect investor assessment of leadership and strategic direction.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-23
Item 5.07
This 8-K Item 5.07 discloses the results of a special stockholder meeting held on July 23, 2026, where shareholders voted on two proposals: (1) adoption of a Merger Agreement with Sun Pharmaceutical entities, which passed with 192.8 million votes for and 2.6 million against, and (2) advisory approval of merger-related executive compensation, which also passed. The disclosure includes voting tallies, quorum information, and record date details—all hallmarks of shareholder vote results. The merger itself is material, and the shareholder approval is a critical milestone in the transaction's completion.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-23
Item 5.02
The Board approved one-time supplemental performance-based stock option grants to current employees including CEO Anand Parikh (398,018 options), General Counsel Christopher Gerry (84,766 options), and SVP Finance Josiah Craver (30,824 options) under the 2026 Equity Incentive Plan. This is a compensatory arrangement for named executives and officers, with vesting contingent on achieving a $70.00 stock price hurdle over a four-year performance period. The disclosure of equity grants to senior management constitutes a material executive compensation event.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-07-23
Item 8.01
The filing discloses a full cashless exercise of 428,862,444 warrants resulting in the issuance of 360,534,431 Class A ordinary shares. This represents a significant dilutive equity issuance—the newly issued shares are restricted but will eventually enter the float, materially affecting share count and ownership percentages. While technically a warrant exercise rather than a primary offering, the economic substance is a dilutive equity issuance that would affect a reasonable investor's assessment of ownership and capital structure.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-07-23
The filing discloses commencement of participant screening in the DReAMzz Phase 2 dose confirmation study for IHL-42X in obstructive sleep apnea, representing a material clinical development milestone. The company notes this is "another major milestone in the advancement of IHL-42X towards Phase III development" and highlights FDA Fast Track designation, positive prior Phase 2 data (83% AHI reduction), and operational progress including CRO appointment and manufacturing completion. This is a significant operational/clinical advancement for a clinical-stage biopharmaceutical company, but does not fit the specific named categories (not earnings, M&A, impairment, litigation, etc.), making operational_other the most appropriate classification.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-07-23
Item 3.03
The company implemented a 1-for-14 reverse stock split, effective July 27, 2026, pursuant to shareholder approval obtained on June 30, 2026. The reverse split modifies the rights of security holders by consolidating shares and required corresponding amendments to the Articles of Incorporation.
View raw filing on EDGAR →
8-K
Financial Other
confidence 72%
filed 2026-07-23
Item 1.01
VPR Brands entered into a License and Release Agreement with JUUL Labs involving an $11 million payment for a patent license and settlement of potential disputes. While this is a material definitive agreement under Item 1.01, it does not constitute a traditional M&A transaction (no acquisition, merger, or change of control), nor does it fit other specific financial categories. The transaction is primarily a licensing and settlement arrangement with significant financial consideration, making it a material financial event that does not fit the M&A taxonomy.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-23
Item 5.07
This Item 5.07 disclosure presents the final voting results from Maison Solutions Inc.'s annual meeting of stockholders held on July 22, 2026. The filing reports detailed vote tallies for two proposals: (1) election of five directors (John Xu, Alexandria M. Lopez, Mark Willis, Bin Wang, and Dr. Xiaoxia Zhang) and (2) ratification of Kreit & Chiu CPA LLP as independent auditors for fiscal year 2027. This is a classic shareholder_vote_results event, as it discloses the outcome of matters voted upon at an annual meeting of security holders.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-07-23
Item 8.01
USA Rare Earth entered into definitive agreements on July 22, 2026, to acquire a strategic minority stake of approximately 13.6% in Carester SAS, a French rare earth processing and separation company, investing EUR 22.5 million in cash and in-kind common stock contributions. The transaction strengthens USAR's European rare earth platform and provides access to Carester's oxide output and engineering capabilities.
View raw filing on EDGAR →
8-K
Governance Other
confidence 82%
filed 2026-07-23
Item 3.03
Greenland Mines' Board adopted a limited-duration stockholder rights plan (poison pill) effective July 22, 2026, granting one right per outstanding common share with a 15% triggering threshold and flip-in/flip-over provisions to protect against hostile takeovers and coercive acquisition tactics. The rights are exercisable at a 50% discount upon triggering, materially affecting shareholder protections and the company's takeover defenses.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-23
Item 5.07
This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting of Stockholders held on July 22, 2026, covering four proposals: director elections, say-on-pay advisory vote, auditor ratification, and a reverse stock split amendment. The filing directly reports vote tallies (For, Against, Withheld/Abstain, Broker Non-Votes) for each proposal, which is the core content of Item 5.07 shareholder vote results disclosures. The reverse stock split proposal is particularly material as it addresses Nasdaq compliance concerns regarding minimum bid price requirements.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-23
Item 5.02
The filing discloses the appointment of Eric Seidel as a director of FreeCast, Inc., effective immediately on July 17, 2026. The Board unanimously approved both the increase in board size from three to four directors and Seidel's appointment to the Board and as the second member of the Audit Committee. This is a clear executive appointment event, material to investors as it affects board composition and governance structure, particularly given the company's Nasdaq listing compliance requirements.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-07-23
The 6-K discloses results of Tokyo Lifestyle Co., Ltd.'s 20th Annual General Meeting of Shareholders held on June 26, 2026. The filing reports shareholder approval of five agenda items: financial statements, Articles of Incorporation amendments, a year-end dividend of JPY1.890 per share, appointment of Sakurazaka Audit Corporation as Accounting Auditor, and appointment of three Corporate Auditors. This is a classic shareholder vote results disclosure under Item 5.07 equivalent, and the dividend approval and auditor/corporate auditor appointments are material governance and capital allocation matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-23
The filing discloses results of a special meeting of stockholders held on June 22, 2026, where shareholders voted on four proposals: extension of the business combination deadline, amendment to the trust agreement, elimination of redemption limitations, and adjournment. Item 5.07 provides detailed voting results for each proposal, with overwhelming approval (1,897,828 FOR votes vs. 900 AGAINST on all substantive proposals). This is a classic shareholder vote results disclosure under Item 5.07, and the outcomes are material to a SPAC's continued operations and timeline.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-23
EX-99.1
Oriental Culture's Board has approved a strategic transition from online e-commerce services for collectibles and artwork to a supporting-services model for third-party platforms, including technology support, warehousing/custodianship, and real estate operations. This is a material shift in the company's core business strategy and revenue model, affecting how the company will operate and generate revenue going forward. While not a discrete M&A transaction, workforce reduction, or other named event type, this strategic pivot is clearly operational and material to investor assessment of the company's future prospects.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-23
The filing discloses the appointment of four officers to Fermi Inc. effective July 22, 2026: George Wentz as General Counsel, Anna Bofa as Chief Commercial Officer, Jacobo Ortiz as Chief Operating Officer, and Rob Masson as Chief Financial Officer. While the filing also includes compensatory arrangements (base salaries, bonuses, equity awards), the principal disclosed action centers on these individuals taking on executive roles. The appointments of a CFO and COO are material to a reasonable investor's assessment of the company's leadership and governance.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-07-23
EX-99.1
PicPay announced receipt of final regulatory approval from Brazil's Central Bank (Bacen) for the acquisition of Kovr Participações S.A., a digital insurance technology company. The press release explicitly states "PicPay will proceed with the remaining steps toward closing the transaction" and describes this as a strategic milestone to build a "comprehensive, end-to-end insurance platform." This is a material acquisition event that would affect investor assessment of the company's growth strategy and financial position.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-23
Item 5.02
Shaun McMeans was appointed as a Class III director of VASO Corporation effective July 23, 2026. The disclosure emphasizes his substantial public company finance and accounting experience, including prior service as CFO of HTG Molecular Diagnostics (2012–2023), and his appointment to the audit committee as a financial expert. Director appointments are material governance events affecting the composition and expertise of the board.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-07-23
Item 3.01
Fly-E Group received a delinquency notification from Nasdaq on July 21, 2026, for non-compliance with Listing Rule 5250(c)(1) due to failure to timely file its Form 10-K. The Notice explicitly states that if the Company fails to regain compliance, "the Company's securities will be subject to delisting from Nasdaq." This is a classic delisting-risk disclosure under Item 3.01, even though the Company filed the 10-K on July 23, 2026, eliminating the immediate compliance issue.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-23
Item 7.01
HeartSciences disclosed a proposed merger with Fortitude Mining Holdings, Inc. under Item 7.01 (Regulation FD Disclosure). The filing references an Agreement and Plan of Merger entered into on June 23, 2026, and announces the company's intention to file a preliminary proxy statement in connection with the "Proposed Transaction." The press release explicitly states the company "believes the Proposed Transaction represents a significant opportunity for its shareholders," indicating a material acquisition/change of control event requiring shareholder approval.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-23
Item 5.02
Mr. Stephen Ilott resigned from the Board of Directors effective July 19, 2026, due to personal reasons. As a board member and Audit Committee member, his departure is a material executive change that affects the composition of the company's governance structure and must be disclosed under Item 5.02.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-07-23
Item 8.01
Zoomcar announced an extension of its warrant-for-common-stock exchange offer, which involves converting outstanding warrants into shares of common stock. This is a dilutive capital transaction that increases the share count and requires stockholder approval to increase authorized shares. While the core event is a warrant exchange rather than a new issuance, the economic effect—dilution of existing shareholders through warrant conversion—aligns most closely with dilutive_issuance. The extension itself is administrative, but the underlying offer materially affects capital structure.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 92%
filed 2026-07-23
The 6-K furnishes a legal opinion validating the remaining $53.9 million of ordinary shares issuable under a Controlled Equity Offering Sales Agreement (ATM offering) with Cantor Fitzgerald and Mizuho Securities. This is a material unregistered equity issuance mechanism that dilutes existing shareholders and signals the company is raising capital through an at-the-market offering, a hallmark disclosure under Item 3.02 equivalent for foreign private issuers.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 94%
filed 2026-07-23
Item 1.01
Change Agents Corporation entered into an Equity Purchase Agreement with Hudson Global Ventures on July 22, 2026, establishing a $10 million equity line of credit whereby the Company may issue shares of common stock at $0.30 per share, plus warrants to purchase 925,925 shares at $0.01 per share. The warrant and shares are offered and sold in reliance on Section 4(a)(2) and Rule 506(b) exemptions under the Securities Act.
View raw filing on EDGAR →
6-K
Earnings release
confidence 92%
filed 2026-07-23
EX-99.1
This is a press release dated July 23, 2026, furnishing preliminary unaudited financial data for Q2 2026 (three months ended June 30, 2026), including revenue of $4.0–$4.1 million and cash position of $31.4 million. Although preliminary and subject to change, it discloses quarterly financial results with material implications: revenue growth, a significant cash decline from $60.0 million (Dec 31, 2025), and explicit going-concern language stating "substantial doubt as to the Company's ability to continue as a going concern." The disclosure also notes potential material impairment charges under evaluation. This is a discrete earnings announcement, not a periodic financial report filing.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-23
The filing discloses entry into a material merger agreement on July 23, 2026, whereby Scancell Holdings plc will acquire Neuphoria Therapeutics Inc. in an all-share transaction. The Merger Agreement specifies the exchange ratio (37.77199 ADSs per Neuphoria share), contingent value rights, closing conditions, and termination rights. This is a change-of-control transaction creating a combined company, clearly falling under Item 1.01 (Entry into a Material Definitive Agreement) and constituting material M&A activity.
View raw filing on EDGAR →
8-K
Operational Other
confidence 73%
filed 2026-07-23
Item 1.01
The Trust entered into three material definitive agreements on July 22–23, 2026: a Third Amendment to the Sponsor Agreement enabling crypto asset staking, an Authorized Participant Agreement with Marex Capital Markets Inc. governing basket creation and redemption, and a Master Purchase and Sale Agreement with JSCT, LLC for digital asset trading. These agreements establish the operational and strategic framework for the Trust's core crypto asset management, trading, and staking functions.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 92%
filed 2026-07-23
Item 7.01
The filing discloses that Nasdaq issued a deficiency letter on April 29, 2026, citing the Company's failure to maintain the minimum $2,500,000 stockholders' equity requirement under Nasdaq Listing Rule 5550(b)(1) as of December 31, 2025. Although the Company states it has regained compliance through recent transactions (a $1.7M equity issuance and $1.485M in recognized revenue), Nasdaq explicitly warned that if compliance is not evidenced at the next periodic report, the Company "may be subject to delisting." This is a classic delisting-risk disclosure under Item 3.01.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-07-23
EX-99.1
MaxsMaking received a Staff Delisting Determination from Nasdaq dated July 17, 2026, stating that Nasdaq has determined to delist the Company's securities pursuant to Nasdaq Listing Rule IM-5101-4. The delisting follows an SEC temporary trading suspension on November 17, 2025, and a Nasdaq trading halt on December 2, 2025. This is a material event that directly threatens the registrant's continued listing and market access.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-07-23
EX-99.1
Safari Flower Company, Aurora's wholly owned subsidiary, has received EU-GMP certification for its Ontario facility, enabling it to serve international medical cannabis markets. This is a material operational and regulatory milestone that strengthens Aurora's global manufacturing capacity and competitive position in regulated international markets (Germany, Poland, UK). While not a discrete M&A event, workforce action, or financial transaction, the certification represents a significant operational achievement that would affect a reasonable investor's assessment of Aurora's ability to execute its international strategy.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-23
Item 2.02
T-Mobile issued a press release on July 23, 2026 announcing Q2 2026 financial and operating results, including service revenues of $19.0 billion (9% YoY growth), net income of $3.2 billion, diluted EPS of $2.99, and Core Adjusted EBITDA of $9.5 billion (12% YoY growth). The disclosure includes detailed quarterly financial metrics, account growth data, and updated 2026 guidance. This is a standard quarterly earnings release furnished as Exhibit 99.1, typical of Item 2.02 disclosures.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-23
Item 2.02
MaxLinear issued a press release on July 23, 2026 announcing unaudited financial results for Q2 2026 ended June 30, 2026, disclosing net revenue of $168.8 million (up 55% year-over-year), gross margin, operating expenses, and diluted EPS, along with forward guidance for Q3 2026. This is a standard quarterly earnings release filed under Item 2.02 and furnished as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-07-23
Item 8.01
EnerSys announced a material revision to its lithium-ion cell manufacturing facility in Greenville, South Carolina, reducing planned capacity from 4–5 gigawatt-hours to 1 gigawatt-hour and refocusing on defense and aerospace applications. The company disclosed a revised $150 million DOE grant (subject to final documentation), a total estimated net investment of $500 million, Board approval, and expected construction commencement in H1 FY2028, representing a significant strategic pivot in capital deployment and business direction.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 95%
filed 2026-07-23
The 6-K furnishes a closing notice for a public distribution offering of R$ 2 billion in simple, non-convertible debentures (bonds) in two series by AXIA Energia S.A. The document announces the completion of the offering under Brazil's automatic registration procedure, with final distribution data showing 159 subscribers for the first series and 81 for the second series. This is a material debt issuance creating a direct financial obligation of two billion reais.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 95%
filed 2026-07-23
The 6-K discloses the payment of Installment 3 of a cash dividend to shareholders of Banco BBVA Argentina S.A. in the amount of $23,003,675,041 ($37.5441433549 per share), with a record date of August 3, 2026 and payment date of August 6, 2026. This is a material dividend distribution authorized by the General Shareholders' Meeting (April 28, 2026), approved by the Argentine Central Bank (May 15, 2026), and confirmed by the Board (May 26, 2026).
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-07-23
The 6-K furnishes AXIA Energia's 2026 Governance Report, disclosing the company's migration to B3's Novo Mercado segment in June 2026, adoption of "one share, one vote" principle, and achievement of 98% adherence to Brazilian Corporate Governance Code practices. This is a governance event reflecting material structural changes to the company's listing status and voting rights, though it does not fit a specific named governance category (not an exec appointment, departure, compensation, or shareholder vote result).
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 45%
filed 2026-07-23
The document is a distance voting ballot for an Extraordinary General Meeting scheduled for 08/28/2026, not a report of voting results. It presents three material merger resolutions (Juno, Tijoá Energia, Retiro Baixo, and NE Janapu) for shareholder approval, but the vote has not yet occurred. This is a pre-meeting disclosure furnishing voting instructions and merger proposals, not a post-meeting results announcement. The most defensible classification is `shareholder_vote_results` as the closest fit, though technically this is a voting ballot preceding the meeting rather than results following it; alternatively, this could be `ma_activity` given the four mergers proposed, but the document's primary function is shareholder voting mechanics rather than M&A announcement.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-07-23
The 6-K furnishes an appraisal report on the net worth of JUNO Participações e Investimentos S.A. as of June 10, 2026, explicitly prepared "for the merger of such Company into AXIA Energia S.A." The report values JUNO's shareholders' equity at R$ 71,717,754.78 and states the merger "shall be submitted for analysis and approval by its shareholders." This is a material acquisition/merger activity requiring shareholder approval.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 75%
filed 2026-07-23
The 6-K furnishes a distance voting ballot for an Extraordinary General Meeting (EGM) scheduled for 08/28/2026, presenting three material merger resolutions: approval of the mergers of Juno Participações, Tijoá Participações, Retiro Baixo Energética, and SPE Nova Era Janapu Transmissora into AXIA Energia. While this is technically a pre-vote notice rather than post-vote results, it discloses the shareholder voting mechanism and substantive M&A activity requiring shareholder approval. The mergers themselves constitute material acquisition activity under the taxonomy, though the document is the voting ballot rather than results announcement.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-07-23
The 6-K furnishes an appraisal report (AP-00651/26-01) dated December 31, 2025, prepared by APSIS CONSULTORIA E AVALIAÇÕES LTDA. for AXIA ENERGIA S.A. The report explicitly states in Section 2 (Purpose of Appraisal) that "The appraisal of SPE NOVA ERA JANAPU shareholders' equity, as of December 31st, 2025, under the terms of Articles 226 and 227 of Brazilian Corporate Law No. 6,404/76, is intended to support the merger of the Company by AXIA ENERGIA." This appraisal of a subsidiary's equity value in support of a merger constitutes a material acquisition or change-of-control activity requiring disclosure under Item 1.01 or 2.01 of the 8-K taxonomy (or equivalent 6-K disclosure).
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-07-23
The 6-K discloses a call for an Extraordinary General Meeting to approve the merger of four wholly-owned subsidiaries (Juno, Tijoá, Retiro Baixo, and Nova Era Janapu) into AXIA Energia. This is a corporate restructuring and governance matter—a simplification of the corporate structure to consolidate operations and strengthen governance. While the mergers involve material subsidiaries operating hydroelectric plants and transmission facilities, the primary disclosure is the shareholder vote required to approve the transaction, making this a governance event rather than an M&A activity (which would apply to acquisitions or dispositions of external entities). The transaction is material to investors as it affects the organizational structure and governance of the company.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-07-23
This 6-K furnishes a management proposal and participation manual for an Extraordinary General Meeting (EGM) scheduled for August 28, 2026. The agenda includes multiple mergers (Juno, Tijoá Energia, Retiro Baixo, and NE Janapu), which constitute material M&A activity requiring shareholder approval. While the document is primarily procedural (digital meeting instructions, voting mechanics, required documentation), the underlying substance—shareholder approval of multiple mergers—is material to investors. The governance event (shareholder vote on M&A) is the material disclosure, though the specific merger details appear to be in exhibits not furnished with this 6-K body.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 25%
filed 2026-07-23
This is a call notice for an Extraordinary General Meeting scheduled for August 28, 2026, not a report of voting results. The document announces shareholder approval items (mergers of Juno, Tijoá Energia, Retiro Baixo, and NE Janapu into AXIA Energia) but does not disclose the outcome of a vote. The proper classification should be governance-related, but the taxonomy lacks a specific "shareholder_meeting_notice" or "shareholder_vote_scheduled" type. This is a pre-vote notice, not a post-vote result.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-07-23
The Fiscal Council of AXIA Energia S.A. issued a favorable opinion on a proposal to merge four subsidiaries (Tijoá Participações e Investimentos S.A., Juno Participações e Investimentos S.A., Retiro Baixo Energética S.A., and Nova Era Janapu Transmissora S.A.) into the parent company. This is a material acquisition/consolidation activity requiring shareholder approval at an Extraordinary General Meeting, directly affecting the registrant's corporate structure and asset base.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-07-23
The 6-K furnishes an appraisal report on the net worth of TIJOÁ Participações e Investimentos S.A. as of June 10, 2026, explicitly prepared for the purpose of a merger of TIJOÁ into AXIA Energia S.A. The report states: "The purpose of the appraisal of the net worth at book value on June 10, 2026 of TIJOÁ Participações e Investimentos S.A. is the merger of such Company into AXIA Energia S.A. ('AXIA'), which shall be submitted for analysis and approval by its shareholders." This is a material acquisition/merger activity requiring shareholder approval, with TIJOÁ valued at R$ 129.1 million in shareholders' equity.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-07-23
The Board of Directors approved the call of an Extraordinary General Meeting on August 28, 2026, to resolve upon the mergers of four wholly-owned subsidiaries (Juno Participações e Investimentos S.A., Tijoá Participações e Investimentos S.A., Retiro Baixo Energética S.A., and SPE Nova Era Janapu Transmissora S.A.) into AXIA Energia S.A. The document details approval of merger protocols, appraisal reports, and authorization for management to implement these mergers—a material change of control and consolidation of subsidiary entities into the parent company.
View raw filing on EDGAR →